Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 8;14(6):548.
doi: 10.3390/ph14060548.

Safety and Benefits of Contraceptives Implants: A Systematic Review

Affiliations
Review

Safety and Benefits of Contraceptives Implants: A Systematic Review

Morena Luigia Rocca et al. Pharmaceuticals (Basel). .

Abstract

Progestin-only contraceptive implants provide long-acting, highly effective reversible contraception. We searched the medical publications in PubMed, CENTRAL, and EMBASE for relevant articles on hormonal implants published in English between 1990 and 2021. Levonorgestrel (LNG) 6-capsule subdermal implants represented the first effective system approved for reversible contraception. The etonogestrel (ENG) single rod dispositive has been widely employed in clinical practice, since it is a highly effective and safe contraceptive method. Abnormal menstrual bleeding is a common ENG side effect, representing the main reason for its premature discontinuation. Emerging evidence demonstrated that it is possible to extend the use of the ENG implant beyond the three-year period for which it is approved. The ENG implant could be an effective and discrete alternative to the IUD in young girls, such as post-partum/post-abortion. Implants should be inserted by trained skilled clinicians who previously provide adequate counselling about their contraceptive effect, benefits, and any possible adverse events. More studies are needed to validate the extended use of the ENG implant for up to 5 years.

Keywords: LARC; contraception; etonogestrel; implanon; levonorgestrel; nexplanon; subdermal implant.

PubMed Disclaimer

Conflict of interest statement

The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

Figures

Figure 1
Figure 1
Flow diagram of study selection.

Similar articles

Cited by

References

    1. Bahamondes L., Fernandes A., Monteiro I., Bahamondes M.V. Long-acting reversible contraceptive (LARCs) methods. Best Pract. Res. Clin. Obstet. Gynaecol. 2020;66:28–40. doi: 10.1016/j.bpobgyn.2019.12.002. - DOI - PubMed
    1. Hubacher D., Spector H., Monteith C., Chen P.L., Hart C. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: A randomized patient preference trial. Am. J. Obstet. Gynecol. 2017;216:101–109. doi: 10.1016/j.ajog.2016.08.033. - DOI - PMC - PubMed
    1. Black A., Guilbert E. Society of Obstetricians and Gynaecologists of Canada. Canadian Contraception Consensus (Part 1 of 4) J. Obstet. Gynaecol. Can. 2015;37:936–942. doi: 10.1016/S1701-2163(16)30033-0. - DOI - PubMed
    1. Black A., Guilbert E. Canadian Contraception Consensus (Part 2 of 4) J. Obstet. Gynaecol. Can. 2015;37:1033–1039. doi: 10.1016/S1701-2163(16)30054-8. - DOI - PubMed
    1. Hindy J.R., Souaid T., Larus C.T., Glanville J., Aboujaoude R. Nexplanon migration into a subsegmental branch of the pulmonary artery: A case report and review of the literature. Medicine. 2020;99:e18881. doi: 10.1097/MD.0000000000018881. - DOI - PMC - PubMed

LinkOut - more resources